Pages that link to "Q41917894"
Jump to navigation
Jump to search
The following pages link to Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes (Q41917894):
Displaying 29 items.
- The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin (Q24802251) (← links)
- Evolution of Fitness Cost-Neutral Mutant PfCRT Conferring P. falciparum 4-Aminoquinoline Drug Resistance Is Accompanied by Altered Parasite Metabolism and Digestive Vacuole Physiology (Q28553454) (← links)
- Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum (Q30658099) (← links)
- A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia (Q33693580) (← links)
- Population pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy (Q33876535) (← links)
- The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death (Q35013756) (← links)
- PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs (Q35149404) (← links)
- New Antimalarial Drugs (Q35581916) (← links)
- Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. (Q35647706) (← links)
- Amino acid efflux by asexual blood-stage Plasmodium falciparum and its utility in interrogating the kinetics of hemoglobin endocytosis and catabolism in vivo (Q36055139) (← links)
- Current opinion on an emergence of drug resistant strains of Plasmodium falciparum through genetic alterations (Q36469382) (← links)
- Defining the timing of action of antimalarial drugs against Plasmodium falciparum (Q36667120) (← links)
- Spirocyclic chromanes exhibit antiplasmodial activities and inhibit all intraerythrocytic life cycle stages (Q36724073) (← links)
- The in-vitro susceptibilities of Ghanaian plasmodium falciparum to antimalarial drugs (Q36841104) (← links)
- Clinical pharmacology of artemisinin-based combination therapies (Q37056580) (← links)
- 4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle (Q37700104) (← links)
- The pharmacogenetics of antimalaria artemisinin combination therapy (Q37928680) (← links)
- Role and Regulation of Glutathione Metabolism in Plasmodium falciparum (Q38523502) (← links)
- Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons (Q39280599) (← links)
- Effects of highly active novel artemisinin–chloroquinoline hybrid compounds on β-hematin formation, parasite morphology and endocytosis in Plasmodium falciparum (Q39539765) (← links)
- Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum (Q40968248) (← links)
- Accelerated denaturation of hemoglobin and the antimalarial action of chloroquine (Q41474052) (← links)
- ATP and luciferase assays to determine the rate of drug action in in vitro cultures of Plasmodium falciparum (Q41811714) (← links)
- Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum (Q41910682) (← links)
- Relationship of chloroquine-induced redistribution of a neutral aminopeptidase to hemoglobin accumulation in malaria parasites (Q41916355) (← links)
- Antimalarial activity of isoquine against Kenyan Plasmodium falciparum clinical isolates and association with polymorphisms in pfcrt and pfmdr1 genes (Q41927719) (← links)
- Mefloquine induces ROS mediated programmed cell death in malaria parasite: Plasmodium (Q46525450) (← links)
- In Vitro Anti-Malarial Interaction and Gametocytocidal Activity of Cryptolepine (Q47101779) (← links)
- Cellular thermal shift assay for the identification of drug-target interactions in the Plasmodium falciparum proteome (Q93271193) (← links)